Evidence map›Paper›PMID 34962339›Full record

ArticleThe Kaohsiung journal of medical sciences2022

Gingerol ameliorates neuronal damage induced by hypoxia-reoxygenation via the miR-210/brain-derived neurotrophic factor axis.

Yang Zhai, Bu-Gu Liu, Xue-Ni Mo, Min Zou, Xiao-Ping Mei, Wei Chen, Guo-Dong Huang, Lin Wu

Open access · goldAbstract read
In one paragraph

Article in The Kaohsiung journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Biomedical reports · 2024
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yang ZhaiGraduate School, Guangxi University of Chinese Medicine, Nanning, China.
Bu-Gu LiuDepartment of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China.
Xue-Ni MoDepartment of Neurology, Guangxi University of Chinese Medicine, Nanning, China.
Min ZouDepartment of Pediatrics, Guangxi International Zhuang Medicine Hospital, Nanning, China.
Xiao-Ping MeiDepartment of Endocrinology, Guangxi International Zhuang Medicine Hospital, Nanning, China.
Wei ChenDepartment of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China.
Guo-Dong HuangDepartment of International Medical, Guangxi International Zhuang Medicine Hospital, Nanning, China.
Lin WuDepartment of Neurology, Guangxi Key Laboratory of Chinese Medicine Foundation Research, Nanning, China.ORCID https://orcid.org/0000-0003-4348-372X
Guangxi University · CNRiverside Hospital of Guangxi Zhuang Autonomous Region · CNThe First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine · CNGuangxi Medical University · CN

Funding

Guangxi Key Laboratory of Chinese Medicine Foundation Research, Guangxi University of Chinese Medicine 19-050-45-01::19-050-45-02Guangxi Key Laboratory of Chinese Medicine Foundation Research, Guangxi University of Chinese Medicine 2018GXKLCMFR110206Guangxi Key Laboratory of Chinese Medicine Foundation Research, Guangxi University of Chinese Medicine K201255801Guangxi University of Chinese Medicine First-class Discipline Project 2019XK024Innovation Project of Guangxi Graduate Education YCBZ2021076Key Research and Development Program of Guangxi Science and Technology Department AB20117002Key Research and Development Program of Guangxi Science and Technology Department AD18281094National Natural Science Foundation of China 81874453Natural Science Foundation of Guangxi Province 2020JJA140299Science and Technology Development Plan Project of Liangqing District 201920Science and Technology Development Plan Project of Liangqing District 201922
6 · The paper itself

Abstract

The specific mechanism of gingerol in cerebral ischemia remains unknown. A neuroprotective function for miR-210 in cerebral ischemia has been identified. The brain-derived neurotrophic factor (BDNF)-mediated signaling pathway protects against cerebral ischemic injury. This investigation aimed to determine whether gingerol plays a neuroprotective role in cerebral ischemia via the miR-210/BDNF axis. N2a cells subjected to 10 h of hypoxia and 4 h of reoxygenation were treated with 5, 10, or 20 μmol/L gingerol. The levels of viability, apoptosis, and proteins in N2a cells were determined using MTT assays, flow cytometry, and western blotting, respectively. The binding relationship between BDNF and miR-210 was studied using a dual luciferase reporter assay. The expression levels of miR-210 and BDNF were determined using qPCR. Gingerol repressed the increase in apoptosis and decrease in viability observed in response to hypoxia/reoxygenation. Gingerol increased Bcl-2, BDNF, and TrkB levels and reduced Bax and cleaved caspase 3 levels after hypoxia/reoxygenation. Gingerol evoked decreased expression of miR-210. Inhibition of miR-210 resulted in increased viability and reduced apoptosis along with increased levels of Bcl-2, BDNF, and TrkB and reduced levels of Bax and cleaved caspase 3 after hypoxia/reoxygenation. Additionally, the miR-210 mimic reversed changes induced by gingerol. The cotransfection of the miR-210 mimic and wild type BDNF led to decreased luciferase activity. BDNF was negatively regulated by miR-210. BDNF siRNA reversed these changes evoked by miR-210 inhibition. Gingerol ameliorated hypoxia/reoxygenation-stimulated neuronal damage by regulating the miR-210/BDNF axis, indicating that gingerol is worthy of further application in cerebral ischemia therapy.

Indexed as

Brain-Derived Neurotrophic FactorBrain IschemiaCatecholsFatty AlcoholsMicroRNAsNeuronsNeuroprotective AgentsAnimalsApoptosisCell Line, TumorMiceBrain-Derived Neurotrophic FactorCatecholsFatty AlcoholsgingerolMicroRNAsMIRN210 microRNA, mouseNeuroprotective AgentsBDNFcerebral ischemiagingerolmiR-210neuroprotection

Identifiers

PMID34962339
PMCPMC11896497
OpenAlexW4200183805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.